Cell viability and proliferation assays revealed that knockdown of DUSP4 could alleviate hypoxia-mediated DOX resistance in GC cells (Figure 7A-7E, Table 6) (***P < 0.001). This evidence concerns the gene DUSP4 and gastric cancer.